FindTrial
Sign In

Study on Application of Levocarnitine in intrahepatic cholestasis of pregnancy

Study on Application of Levocarnitine in intrahepatic cholestasis of pregnancy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015136
Enrollment
Unknown
Registered
2018-03-09
Start date
2018-03-01
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrahepatic cholestasis of pregnancy

Interventions

group Levocarnitine:Levocarnitine
group UDCA:Ursodeoxycholic acid
group UDCA+SAME:S- adenosylmethionine+UDCA

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Definitive diagnosis of intrahepatic cholestasis of pregnancy(ICP)

Exclusion criteria

Exclusion criteria: Intrauterine demise,no need to use drug or need to terminate the pregnancy immediately in women with ICP.

Design outcomes

Primary

MeasureTime frame
Bile acid;serum aminotransferases;Lipid;Delivery outcome;—

Countries

China

Contacts

Public ContactHuishu Liu

Guangzhou Women and Children's Medical Center

huishuliu@hotmail.com+86 13924152738

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026